Two new anti-inflammatory drugs may boost recovery from COVID-19

Two new anti-inflammatory drugs may boost recovery from COVID-19
Credit: CC0 Public Domain
In two new studies, researchers found that two anti-inflammatory compounds are capable of accelerating recovery from COVID-19.
They found the monoclonal antibody eculizumab and an experimental drug called AMY-101 had strong anti-inflammatory effects that contributed to a faster recovery by severe COVID-19 patients.
The two medications were administered separately. The monoclonal antibody, routinely used to treat blood diseases, was tested on patients at the teaching hospital in the University of São Paulo.
AMY-101, a candidate drug developed by US-based pharmaceutical company Amynda, was given to patients at a hospital in Milan, Italy.

Related Keywords

Milan , Lombardia , Italy , Brazil , Rodrigo Calado , University Of Pennsylvania , , மிலன் , லோம்பார்டியா , இத்தாலி , பிரேசில் , ரோட்ரிகோ கேளடா , பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா ,